Category Archives: XBI

Reading the Tape: Biotech

October 16, 2026 By in $SPSIBI, Biotech, SPBIO, Wyckoff, Wyckoff Stock Market Institute, XBI, XBI-26-24 Leave a comment

Once You See It.

Legend has it, Wyckoff locked himself in a room with nothing but a stock ticker and telephone; working many hours to decipher what the tape was telling him.

Later, the result of that effort was presented in his seminal text, Studies In Tape Reading, first published in 1910.

One of, if not the most important concept of that effort (also in his training materials) was, ‘What’s the market saying about itself?’

We’re going to use that idea to look at the biotech sector and specifically XBI.

Biotech XBI, Daily

There it is:

We have at least three significant thrusts lower; four if you count the one on August 28th, all of which suggest that XBI is in ‘distribution’ (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech Downtrend

October 15, 2026 By in Biotech, SPBIO, Charles Dow, $SPSIBI, XBI, Linda Raschke, XBI-26-24 Leave a comment

Meets the Definition

We just had a reminder days ago, from Linda Raschke, about the definition of a price action ‘trend’.

For a downtrend, it’s lower lows and lower highs.

When looking at biotech XBI, that’s what we have; a downtrend (not advice, not a recommendation).

Biotech XBI, Daily

At this point, we’re between ‘spring’ and ‘resistance’.

We see the Fibonacci sequence comes and goes; next up is ‘Day 55’.

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Moderna’s ‘Measured Move’

October 12, 2026 By in $SPSIBI, Biotech, DIA, Dow 30, Financial Sector, IBB, IYR, MRNA, Nasdaq, Real Estate, S&P, S&P 500, SOXX, SPBIO, XBI, XLF, XLV Leave a comment

From Resistance To Wedge … and Back?

The last update on Moderna, here, said that price action had slammed into resistance.

The chart shows that MRNA, has gone from resistance. to wedge, to measured move.

With the S&P and Qs, stalled at all-time highs, SOXX, DIA, XLF, IYR well off their highs with the biotech sector in an apparent reversal, one has to wonder what’s next (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Quarterly Chart … XBI

October 9, 2026 By in Biotech, SPBIO, $SPSIBI, XBI, XBI-26-21

The Really Big Picture

One of the few indices or sectors that has not made new all-time highs, is Biotech XBI.

In the case at left, XBI spent an entire quarter pinned against resistance, going nowhere.

Now, in the first week or so of the current quarter, XBI is edging away from the highs (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

The Price is (always) Right

October 7, 2026 By in $SPSIBI, LABD, LABD-26-18, SNDK, SPBIO, XBI

XBI, Two Days Later

The last post on biotech (LABD) was here, showing a potential trendline.

Next day, within minutes of the open, XBI began a collapse and inverse fund LABD launched higher, finishing up +9.93%, for the day.

From an analysis standpoint, the dramatic action suggests trendline(s) may need to be re-drawn.

We’re going to switch back to the XBI ETF, as it shows the situation more clearly.

Biotech XBI, Daily

There may be other channels in effect, yet to reveal themselves.

Expectation is for continued lower action, it’s up to the market.

The channel could easily be negated if tomorrow is decidedly higher as just happened with SNDK (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Decision Point … Biotech

October 5, 2026 By in $SPSIBI, Biotech, LABD, LABD-26-18, SPBIO, XBI, XBI-26-17 1 Comment

At The Edge of Trend

We’re looking at biotech XBI, from the perspective of the 3X Leveraged Inverse Fund, LABD.

During the past four trading days, there have been three contact (verification) points on the right-most trendline.

Note that five trading days ago, LABD had its highest volume day, ever.

Trade Note:

The XBI-26-17 (short) was exited at about break-even, then re-positioned via LABD, as LABD-26-18 (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech’s Bearish Condition

October 4, 2026 By in $SPSIBI, BBIO, SPBIO, Speck-Effect, The Speck, XBI, XBI-26-17

Technical First

Depending on price action, the next several updates on XBI, will discuss the technical condition.

Then, we’ll get into behind-the-scenes or ‘fundamentals’.

With that said, we’ll start with the big picture, long timeframe; Fibonacci 8-Day

Biotech XBI, 8-Day

Price action has made it all the way back to 2021 manic highs, and stalled.

A potential double top.

Not present back in 2021, was the bearish (divergent) momentum condition highlighted by MACD histogram.

So, we have a potential double top, a terminating wedge and bearish MACD.

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

S&P … Almost ‘There’

October 3, 2026 By in $SPSIBI, AZO, Biotech, BKNG, DUOL, HD, KMX, LOW, S&P, S&P 500, Semiconductors, SPBIO, Speck-Effect, SPY, The Speck, XBI, XBI-26-17

‘There’, is a new All-Time High

Two weeks ago, was this update showing the (net) upward progress of the S&P was slowing (not advice, not a recommendation).

Then, two days later was this, presenting how the index might make it to another high.

Now, the SPY chart is mimicking the longer timeframe by having successive shorter thrusts (magenta arrows).

At this point it’s a toss-up but does it really matter?

Meaning, if the downside is being worked (shorted), large numbers of tickers are already in essentially free-fall: AZO, BKNG, DUOL, HD, KMX, LOW; way below their all-time highs (not advice, not a recommendation).

Note: All have been covered at some point, on this site.

One sector that’s not cracked (yet) but seems to be building up immense pressure, is biotech.

Barring any unforeseen event, XBI is covered next.

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech Top … So, Far

September 29, 2026 By in $SPSIBI, Biotech, SPBIO, Up-Thrust, XBI, XBI-26-16

Subdividing Lower

Looking at the chart from left-to-right, the peaks are lower and the lows, are lower.

As noted, today was an apparent up-thrust (reversal), with a test coming towards the close.

After-hours action (as of 7:40 p.m., EST) is holding steady; no movement up or down.

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

The Axis of Biotech

September 28, 2026 By in $SPSIBI, Biotech, SPBIO, XBI, XBI-26-16

Underside Test

The chart segment of XBI shows its posted an axis line over the past few months.

There have been oscillations on both sides, with today being an underside test.

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279